Status:
UNKNOWN
TDF and Entekavir - Hepatitis B Reactivation
Lead Sponsor:
Viral Hepatitis Society
Conditions:
Hepatitis B Reactivation
Eligibility:
All Genders
18+ years
Brief Summary
This is a non-interventional retrospective multi-center study for the patients received Entekavir or TDF for Hepatitis B prophylaxis.
Eligibility Criteria
Inclusion
- Patients used entekavir or TDF for Hepatitis B prophylaxis
Exclusion
- Patients lower then 18 years old.
Key Trial Info
Start Date :
January 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT06049602
Start Date
January 15 2023
End Date
December 31 2023
Last Update
September 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cerrahpasa Medical Faculty
Istanbul, Turkey (Türkiye)